Bicellar systems as a new colloidal delivery strategy for skin

Colloids and Surfaces B: Biointerfaces

Volumn 92, Issue , 2012, Pages 322-326

  Rubio, L ^a   Rodriguez G ^a   Barbosa Barros, L ^a   Alonso, C ^a   Cocera M ^a   de la Maza, A ^a   Parra, J L ^a   Lopez O ^a  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

Author keywords

Bicellar systems; Cryo transmission electron microscopy; Diclofenac; Dihexanoyl glycero phosphatidylcholine; Dimyristoyl glycero phosphatidylcholine; Dipalmitoyl glycero phosphatidylcholine; Flufenamic acid; In vitro percutaneous absorption

Indexed keywords

CRYO-TRANSMISSION ELECTRON MICROSCOPY; DICLOFENAC; DIHEXANOYL-GLYCERO-PHOSPHATIDYLCHOLINE; DIMYRISTOYL-GLYCERO-PHOSPHATIDYLCHOLINE; DIPALMITOYL-GLYCERO-PHOSPHATIDYLCHOLINE; FLUFENAMIC ACID; IN VITRO PERCUTANEOUS ABSORPTION;

DYNAMIC LIGHT SCATTERING; PHOSPHOLIPIDS;

TRANSMISSION ELECTRON MICROSCOPY;

ALCOHOL; DICLOFENAC DIETHYLAMINE; DIHEXANOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DRUG CARRIER; FLUFENAMIC ACID; GLYCEROPHOSPHOLIPID; NANOMATERIAL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BICELLAR DELIVERY SYSTEM; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; COSMETIC INDUSTRY; CRYOGENIC TRANSMISSION ELECTRON MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG MIXTURE; HYDROGEN BOND; LIGHT SCATTERING; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION; SKIN SURFACE; SWINE; TRANSMISSION ELECTRON MICROSCOPY;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANIMALS; COLLOIDS; CRYOELECTRON MICROSCOPY; DRUG DELIVERY SYSTEMS; MICELLES; PHOSPHOLIPID ETHERS; SKIN ABSORPTION; SUS SCROFA;

EID: 84856101438     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.12.005     Document Type: Article

References (42)

1. Barry B.W. Eur. J. Pharm. Sci. 2001, 14:101.
2. Honeywell-Nguyen P.L., Bouwstra J.A. Drug Discov. Today: Technol. 2005, 2:67.
3. Williams A.C. Transdermal and Topical Drug Delivery: From Theory to Clinical Practice 2003, Pharmaceutical Press, London.
4. Visscher I., Stuart M.C., Engberts J.B. Org. Biomol. Chem. 2006, 4:707.
5. Vold R.R., Prosser R.S. J. Magn. Res. Ser. B 1996, 113:267.
6. Prosser R.S., Evanics F., Kitevski J.L., Al-Abdul-Wahid M.S. Biochemistry 2006, 45:8453.
7. Barbosa-Barros L., de la Maza A., Estelrich J., Linares A.M., Feliz M., Walther P., Pons R., Lopez O. Langmuir 2008, 24:5700.
8. Barbosa-Barros L., De la Maza A., Walther P., Estelrich J., Lopez O. J. Microsc. 2008, 230:16.
9. Rodriguez G., Barbosa-Barros L., Rubio L., Cocera M., Lopez-Iglesias C., de la Maza A., Lopez O. Colloids Surf. 2011, 84:390.
10. Almeida P.F., Vaz W.L., Thompson T.E. Biochemistry 1992, 31:6739.
11. Vist M.R., Davis J.H. Biochemistry 1990, 29:451.
12. Golden G.M., Guzek D.B., Kennedy A.H., McKie J.E., Potts R.O. Biochemistry 1987, 26:2382.
13. OECD Guideline 428: Skin Absorption: In Vitro Method. OECD Guidelines for the Testing of Chemicals 2004, 8. OECD Publishing, Paris, France. O.f.E.C.a. Development (Ed.).
14. Schaefer H., Redermeier T.E. Skin Barrier-Principles of Percutaneous Absorption 1996, Karger-Verlag, Basel.
15. Elias P.M., Feingold K.R. Skin Barrier 2006, Taylor and Francis group, New York.
16. Gwak H.S., Chun I.K. Int. J. Pharm. 2002, 236:57.
17. Galer B.S., Rowbotham M., Perander J., Devers A., Friedman E. J. Pain Symptom Manag. 2000, 19:287.
18. Wagner H., Kostka K.H., Adelhardt W., Schaefer U.F. Eur. J. Pharm. Biopharm. 2004, 58:121.
19. Van Dam L., Karlsson G., Edwards K. Biochim. Biophys. Acta 2004, 1664:241.
20. Whiles J.A., Deems R., Vold R.R., Dennis E.A. Bioorg. Chem. 2002, 30:431.
21. Probstein R.F. Physicochemical Hydrodynamics 1994, John Wiley & Sons, New York.
22. Honeywell-Nguyen P.L., Frederik P.M., Bomans P.H., Junginger H.E., Bouwstra J.A. Pharm. Res. 2002, 19:991.
23. Barbosa-Barros L., Barba C., Rodríguez G., Cócera M., Coderch L., López-Iglesias C., de la Maza A., López O. Mol. Pharm. 2009, 6:1237.
24. Wang H., de Joannis J., Jiang Y., Gaulding J.C., Albrecht B., Yin F., Khanna K., Kindt J.T. Biophys. J. 2008, 95:2647.
25. Lopes L.B., Scarpa M.V., Silva G.V., Rodrigues D.C., Santilli C.V., Oliveira A.G. Colloids Surf. 2004, 39:151.
26. Kriwet K., Müller-Goymann C.C. Pharmazie 1994, 49:187.
27. Lopes L.B., Scarpa M.V., Pereira N.L., Oliveira L.C., Oliveira A.G. Rev. Bras. Cienc. Farm. 2006, 42:497.
28. Rades T., Müller-Goymann C.C. Int. J. Pharm. 1997, 159:215.
29. Schreier S., Malheiros S.V., de Paula E. Biochim. Biophys. Acta 2000, 1508:210.
30. Schutze W., Muller-Goymann C.C. Pharm. Res. 1998, 15:538.
31. López-Fontán J.L., Martínez-Landeira P., Santamarina C., Ruso J.M., Prieto G., Sarmiento F. Prog. Colloid Polym. Sci. 2003, 122:141.
32. Santander-Ortega M.J., Stauner T., Loretz B., Ortega-Vinuesa J.L., Bastos-Gonzalez D., Wenz G., Schaefer U.F., Lehr C.M. J. Control Release 2010, 141:85.
33. Struppe J., Whiles J.A., Vold R.R. Biophys. J. 2000, 78:281.
34. Boinpally R.R., Zhou S.L., Poondru S., Devraj G., Jasti B.R. Eur. J. Pharm. Biopharm. 2003, 56:389.
35. Parsaee S., Sarbolouki M.N., Parnianpour M. Int. J. Pharm. 2002, 241:185.
36. Kweon J.H., Chi S.C., Park E.S. Arch. Pharm. Res. 2004, 27:351.
37. Jacobi U., Taube H., Schafer U.F., Sterry W., Lademann J. J. Control Release 2005, 103:61.
38. Hadgraft J., Peck J., Williams D.G., Pugh W.J., Allan G. Int. J. Pharm. 1996, 141:17.
39. Asbill C.S., Michniak B.B. PSTT 2000, 3:36.
40. Fang J.Y., Hwang T.L., Leu Y.L. Int. J. Pharm. 2003, 250:313.
41. Thong H.Y., Zhai H., Maibach H.I. Skin Pharmacol. Physiol. 2007, 20:272.
42. Frolich M.A., Giannotti A., Modell J.H. Anesth. Analg. 2001, 93:647.